Article ID Journal Published Year Pages File Type
6113681 Critical Reviews in Oncology/Hematology 2013 15 Pages PDF
Abstract
We discuss the general benefits of estrogen therapy to quality of life of men on ADT, the potential risks of this treatment, and possible treatment regimes for estrogen therapy in males. Unless contraindicated, we propose that PCa patients on ADT would benefit from supplemental parenteral estrogen.
Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, ,